Checkpoint Surgical said today that it raised another $9 million for the handheld nerve monitor it’s developing. The Cleveland-based company said the $8.8 million round was led by Mutual Capital Partners and included prior backers First Analysis, the JumpStart NEXT Fund and several individual investors. Checkpoint said it plans to use the proceeds to build out its sales […]
Featured
LeMaitre Vascular ponies up $14m for Applied Medical’s clot management tech
LeMaitre Vascular (NSDQ:LMAT) this week ponied up $11 million in cash and another $3 million in post-closing payments for the vascular clot business at Applied Medical Resources Corp. The Burlington, Mass.-based company said the $14.2 million deal includes a one-year transition services provision that will see Applied Medical manufacture the devices for LeMaitre. The deal covers […]
Cardiawave raises $8.2 million for non-invasive aortic stenosis device
Parisian startup Cardiawave has raised more than $8 million to boost development of its ultrasound device to treat calcific aortic stenosis. Nearly $3 million came from the European program Instrument PME, which finances disruptive European technologies developed by potentially high-growth companies. Family-controlled investment groups and the company’s traditional shareholders — Sofimac Innovation, Business Angels des Grandes […]
Acquisitions hit earnings for AngioDynamics Q1
AngioDynamics (NSDQ:ANGO) took an earnings hit during its fiscal first quarter on increased acquisition expenses, but raised its sales outlook for the rest of the year. Losses grew 1,240% to -$469 million, or -1¢ per share, on flat sales of $85.3 million for the three months ended August 31. Adjusted to exclude one-time items – including […]
Cantel Medical slides in Q4 earnings miss
Cantel Medical (NYSE:CMN) shares came under pressure today after the medical device company missed expectations with its fiscal fourth-quarter and full-year earnings. Little Falls, N.J.-based Cantel posted profits of $16.9 million, or 41¢ per share, on sales of $228.9 million for the three months ended July 31, for flat profit growth on an 11.4% top-line gain […]
Ra Medical prices up-sized $66m IPO
Ra Medical yesterday priced an initial public offering worth more than $66 million, significantly higher than the range it indicated last week. The Carlsbad, Calif.-based company said Sept. 17 that it planned to float 3.3 million shares at $14 to $16 apiece, for gross proceeds of $46.7 million to $53.3 million. At the midpoint the flotation […]
Hologic to buy Focal Therapeutics for $125m
Hologic (NSDQ:HOLX) said today it inked a $125 million deal to acquire bioresorbable tissue marker developer Focal Therapeutics. Aliso Viejo, Calif.-based Focal Therapeutics produces the BioZorb bioresorbable, three-dimensional tissue marker which is intended to improve lumpectomy surgeries by marking the tumor excision site for monitoring and future treatments. Hologic said that it will add the BioZorb marker […]
TCT 2018: Abbott touts low rates of stroke, death in 1-year Portico TAVR study
Abbott (NYSE:ABT) today released one-year results from a study exploring the use of its Portico transcatheter aortic valve replacement system in patients with symptomatic, severe aortic stenosis, touting low rates of stroke, death and leaks between the valve and native heart tissue. Results from the Portico 1 study were presented during a late-breaking session at the Transcatheter […]
Medtech isn’t spending enough on R&D, report says
The medical technology industry put more into share buybacks and dividends to investors than it spent on R&D last year and that’s not good for its long-term prospects, according to a new report from Ernst & Young. The advisory firm’s 12th annual “Pulse of the Industry” report looked at therapeutic device, diagnostic, drug delivery and analytical/life […]
Gore adds $10m to ViaCyte investment
W.L. Gore put up a $10 million convertible note for ViaCyte and the Type I diabetes treatment they’re working on. Last year the companies inked a deal to work on the synthetic pancreas ViaCyte is developing. The San Diego-based company’s Encaptra device is designed to be seeded with stem cells engineered to become pancreatic cells and implanted under the skin. […]
Ex-MiMedx brass blast back
Some of the former top brass at MiMedx (NSDQ:MDXG), who were let go over the summer for what the company later determined to be “for cause,” said that their ousters were part of an out-of-control internal investigation. Last week MiMedx, which makes regenerative and therapeutic biologics using human placental tissue allografts, said a probe into its accounting practices […]